PRGO
Perrigo Company plc · Healthcare · Drug Manufacturers - Specialty & Generic
Todas las cifras de propiedad: únicamente gestores 13F seguidos, posiciones en acciones ordinarias, período de referencia Q2 2024
| Trimestre | Titulares | Δ | Acciones | Valor declarado | Nuevo | Cierres |
|---|---|---|---|---|---|---|
| Q2 2026 | 101 | +2 | 113.09M | $1.17B | +10 | −7 |
| Q1 2026 | 101 | +4 | 101.94M | $1.09B | +11 | −8 |
| Q4 2025 | 98 | -2 | 106.62M | $1.48B | +3 | −4 |
| Q3 2025 | 19 | 0 | 63.63M | $1.42B | +1 | −2 |
| Q2 2025 | 17 | 0 | 58.29M | $1.56B | — | — |
| Q1 2025 | 14 | +1 | 29.73M | $833.59M | +1 | — |
| Q4 2024 | 13 | -2 | 24.99M | $642.39M | — | −2 |
| Q3 2024 | 14 | -1 | 13.07M | $342.69M | — | −1 |
| Q2 2024 | 15 | — | 10.85M | $278.70M | — | — |
| # | Gestor | Acciones | Δ acciones | Valor | Su ponderación | Mantenida | ||
|---|---|---|---|---|---|---|---|---|
| 1 | Geode Capital Management ✦ (pasivo) | 2.25M | — | $57.87M | 0.0% | n/c | 1 | SEC ↗ |
| 2 | Geode Capital Management ✦ (pasivo) | 2.25M | — | $57.87M | 0.0% | n/c | 1 | SEC ↗ |
| 3 | Citadel Advisors ✦ | 2.22M | — | $56.96M | 0.1% | n/c | 1 | SEC ↗ |
| 4 | Citadel Advisors ✦ | 2.22M | — | $56.96M | 0.1% | n/c | 1 | SEC ↗ |
| 5 | Norges Bank ✦ (pasivo) | 1.37M | — | $35.11M | 0.0% | n/c | 1 | SEC ↗ |
| 6 | AQR Capital Management ✦ | 970.64K | — | $24.93M | 0.0% | n/c | 1 | SEC ↗ |
| 7 | AQR Capital Management ✦ | 970.64K | — | $24.93M | 0.0% | n/c | 1 | SEC ↗ |
| 8 | AQR Capital Management ✦ | 970.64K | — | $24.93M | 0.0% | n/c | 1 | SEC ↗ |
| 9 | Wellington Management ✦ | 819.55K | — | $21.05M | 0.0% | n/c | 1 | SEC ↗ |
| 10 | Wellington Management ✦ | 819.55K | — | $21.05M | 0.0% | n/c | 1 | SEC ↗ |
| 11 | Wellington Management ✦ | 819.55K | — | $21.05M | 0.0% | n/c | 1 | SEC ↗ |
| 12 | GAMCO Investors ✦ | 797.09K | — | $20.47M | 0.2% | n/c | 1 | SEC ↗ |
| 13 | Renaissance Technologies ✦ | 762.41K | — | $19.58M | 0.0% | n/c | 1 | SEC ↗ |
| 14 | Millennium Management ✦ | 451.92K | — | $11.61M | 0.0% | n/c | 1 | SEC ↗ |
| 15 | Arrowstreet Capital ✦ | 436.65K | — | $11.21M | 0.0% | n/c | 1 | SEC ↗ |
| 16 | Two Sigma Investments ✦ | 273.20K | — | $7.02M | 0.0% | n/c | 1 | SEC ↗ |
| 17 | D. E. Shaw & Co. ✦ | 249.42K | — | $6.41M | 0.0% | n/c | 1 | SEC ↗ |
| 18 | T. Rowe Price ✦ | 108.37K | — | $2.78M | 0.0% | n/c | 1 | SEC ↗ |
| 19 | T. Rowe Price ✦ | 108.37K | — | $2.78M | 0.0% | n/c | 1 | SEC ↗ |
| 20 | Gotham Asset Management ✦ | 91.47K | — | $2.35M | 0.0% | n/c | 1 | SEC ↗ |
| 21 | Bridgewater Associates ✦ | 39.17K | — | $1.01M | 0.0% | n/c | 1 | SEC ↗ |
| 22 | Marshall Wace ✦ | 14.20K | — | $364,656 | 0.0% | n/c | 1 | SEC ↗ |
«Su ponderación» = la participación de la posición en el valor de renta variable 13F declarado por ese gestor — la medida de convicción. ✦ = gestor seleccionado.
Nuevos compradores
| Sin nuevos compradores rastreados este trimestre. |
Posición cerrada
| Sin salidas rastreadas este trimestre. |
Contexto de mercado completo: entre TODOS los filers 13F (datos estructurados SEC, Q1 2026): 326 tenedores, 151.12M acciones, $1.41B declarado. Este es un período diferente y anterior al de las cifras del universo rastreado que figuran arriba, y ambos nunca se mezclan.
Qué otros valores suelen tener también los tenedores rastreados de este activo — recuentos de cotenencia, no relaciones fundamentales.